Rapid Micro Biosystems Announces the Commercial Availability of the Growth Direct MultiTest System

Rapid Micro Biosystems, the provider of automated, rapid, non-destructive detection and enumeration technologies in microbiology, today announced the continued expansion of the Growth Direct(TM) product line with the launch of the Growth Direct MultiTest System.  The technology automates the incubation, detection, and results reporting steps for bioburden, environmental monitoring and sterility testing -- within a single instrument.  The proven method is based on the detection of the natural auto-fluorescence of microorganisms, and can detect growing colonies in about half the time of the traditional tests, providing time and resource savings.

The MultiTest System expands the existing Growth Direct(TM) technology platform currently used in FDA regulated manufacturing facilities.

"Companies have been looking for a way to increase their efficiency, reduce errors and deliver results more quickly across the portfolio of tests they conduct," states Julie Sperry, Chief Commercial Officer. "The Growth Direct MultiTest is unique in its ability to run all the applications concurrently on the same system."

"Using a single, automated, self-contained microbial QC testing system changes the way that businesses view rapid methods for their quality control labs," said Robert Spignesi, President and CEO of Rapid Micro Biosystems. "Companies now have the option to perform all their key tests on a single platform versus the inefficiencies in validation, training and maintenance of deploying unique solutions for each application.  This allows QC labs to see the benefits while minimizing their up-front investment."